Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients

Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients

IntroductionCurrently there are no biomarkers that are predictive of when patients with type-2 diabetes (T2D) will progress to more serious kidney disease i.e., diabetic nephropathy (DN). Biomarkers that could identify patients at risk of progression would allow earlier, more aggressive treatment in...

Full description

Bibliographic Details
Main Authors: Carla Harkin, Diego Cobice, Simon Brockbank, Stephanie Bolton, Frances Johnston, Anna Strzelecka, Joanne Watt, Mary Jo Kurth, John V. Lamont, Peter Fitzgerald, Tara Moore, Mark W. Ruddock
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
diabetic nephropathy
midkine
sTNFR1
sTNFR2
L-FABP
H-FABP
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.887237/full

Similar Items

Similar Items